SAGE-Hindawi Access to Research Stroke Research and Treatment Volume 2011, Article ID[removed], 7 pages doi:[removed][removed]Review Article

First Page		Document Content
Date: 2014-03-26 10:08:06 Rare diseases Fabry disease Enzyme replacement therapy Lysosomal storage disease Stroke Aspirin Fabry Robert J. Desnick Health Medicine Lipid storage disorders		SAGE-Hindawi Access to Research Stroke Research and Treatment Volume 2011, Article ID[removed], 7 pages doi:[removed][removed]Review Article Add to Reading List Source URL: downloads.hindawi.com Download Document from Source Website File Size: 1,19 MB Share Document on Facebook

	Migalastat and Enzyme Replacement Therapy Have Comparable Effects on Renal Function in Fabry Disease: Phase 3 Study Results Nicholls, K1*, Bichet, DG2, Giugliani, R3, Hughes, D4, Schiffmann, R5, Wilcox, W6, Skuban, N7, R DocID: 1tiPw - View Document
	The Journal of Rare Disorders CochraneCorner DocID: 19CDW - View Document
	7 November 2014 Dear Committee Re: Life Saving Drugs Programme Review Fabry Support Group of Australia Submission DocID: W87d - View Document
	Minimum Recommended Schedule of Assessments for MPS I Patients Initial Assessments Every 6 DocID: VV2Y - View Document
	Pancreatic enzyme replacement therapy DocID: V3Jk - View Document